• Something wrong with this record ?

Responsiveness and meaningful improvement of mobility measures following MS rehabilitation

I. Baert, T. Smedal, A. Kalron, K. Rasova, A. Heric-Mansrud, R. Ehling, I. Elorriaga Minguez, U. Nedeljkovic, A. Tacchino, P. Hellinckx, G. Adriaenssens, G. Stachowiak, K. Gusowski, D. Cattaneo, S. Borgers, J. Hebert, U. Dalgas, P. Feys,

. 2018 ; 91 (20) : e1880-e1892. [pub] 20181017

Language English Country United States

Document type Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19034960

OBJECTIVE: To determine responsiveness of functional mobility measures, and provide reference values for clinically meaningful improvements, according to disability level, in persons with multiple sclerosis (pwMS) in response to physical rehabilitation. METHODS: Thirteen mobility measures (clinician- and patient-reported) were assessed before and after rehabilitation in 191 pwMS from 17 international centers (European and United States). Combined anchor- and distribution-based methods were used. A global rating of change scale, from patients' and therapists' perspective, served as external criteria when determining the area under the receiver operating characteristic curve (AUC), the minimally important change (MIC), and the smallest real change (SRC). Patients were stratified into 2 subgroups based on disability level (Expanded Disability Status Scale score ≤4 [n = 72], >4 [n = 119]). RESULTS: The Multiple Sclerosis Walking Scale-12, physical subscale of the Multiple Sclerosis Impact Scale-29 (especially for the mildly disabled pwMS), Rivermead Mobility Index, and 5-repetition sit-to-stand test (especially for the moderately to severely disabled pwMS) were the most sensitive measures in detecting improvements in mobility. Findings were determined once the AUC (95% confidence interval) was above 0.5, MIC was greater than SRC, and results were comparable from the patient and therapist perspective. CONCLUSIONS: Responsiveness, clinically meaningful improvement, and real changes of frequently used mobility measures were calculated, showing great heterogeneity, and were dependent on disability level in pwMS.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034960
003      
CZ-PrNML
005      
20191008110905.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1212/WNL.0000000000006532 $2 doi
035    __
$a (PubMed)30333161
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Baert, Ilse $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark. ilse.baert@uhasselt.be.
245    10
$a Responsiveness and meaningful improvement of mobility measures following MS rehabilitation / $c I. Baert, T. Smedal, A. Kalron, K. Rasova, A. Heric-Mansrud, R. Ehling, I. Elorriaga Minguez, U. Nedeljkovic, A. Tacchino, P. Hellinckx, G. Adriaenssens, G. Stachowiak, K. Gusowski, D. Cattaneo, S. Borgers, J. Hebert, U. Dalgas, P. Feys,
520    9_
$a OBJECTIVE: To determine responsiveness of functional mobility measures, and provide reference values for clinically meaningful improvements, according to disability level, in persons with multiple sclerosis (pwMS) in response to physical rehabilitation. METHODS: Thirteen mobility measures (clinician- and patient-reported) were assessed before and after rehabilitation in 191 pwMS from 17 international centers (European and United States). Combined anchor- and distribution-based methods were used. A global rating of change scale, from patients' and therapists' perspective, served as external criteria when determining the area under the receiver operating characteristic curve (AUC), the minimally important change (MIC), and the smallest real change (SRC). Patients were stratified into 2 subgroups based on disability level (Expanded Disability Status Scale score ≤4 [n = 72], >4 [n = 119]). RESULTS: The Multiple Sclerosis Walking Scale-12, physical subscale of the Multiple Sclerosis Impact Scale-29 (especially for the mildly disabled pwMS), Rivermead Mobility Index, and 5-repetition sit-to-stand test (especially for the moderately to severely disabled pwMS) were the most sensitive measures in detecting improvements in mobility. Findings were determined once the AUC (95% confidence interval) was above 0.5, MIC was greater than SRC, and results were comparable from the patient and therapist perspective. CONCLUSIONS: Responsiveness, clinically meaningful improvement, and real changes of frequently used mobility measures were calculated, showing great heterogeneity, and were dependent on disability level in pwMS.
650    _2
$a dospělí $7 D000328
650    _2
$a terapie cvičením $x metody $7 D005081
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pohybová aktivita $x fyziologie $7 D009043
650    _2
$a roztroušená skleróza $x rehabilitace $7 D009103
650    12
$a výsledek terapie $7 D016896
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Smedal, Tori $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Kalron, Alon $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Rasova, Kamila $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Heric-Mansrud, Adnan $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Ehling, Rainer $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Elorriaga Minguez, Iratxe $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Nedeljkovic, Una $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Tacchino, Andrea $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Hellinckx, Peter $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Adriaenssens, Greet $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Stachowiak, Gosia $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Gusowski, Klaus $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Cattaneo, Davide $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Borgers, Sophie $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Hebert, Jeffrey $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Dalgas, Ulrik $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
700    1_
$a Feys, Peter $u From the REVAL Rehabilitation Research Center (I.B., P.F.), BIOMED Biomedical Research Institute, Faculty of Medicine & Life Sciences, Hasselt University, Belgium; Haukeland University Hospital (Norwegian MS Competence Centre and Department of Physiotherapy) (T.S.), Bergen, Norway; Department of Physical Therapy (A.K.), Sackler Faculty of Medicine, Tel-Aviv University; Multiple Sclerosis Center (A.K.), Sheba Medical Center, Tel-Hashomer, Israel; Department of Rehabilitation, Third Faculty of Medicine (K.R.), Charles University and Faculty Hospital Royal Vineyards, Prague, Czech Republic; Multiple Sclerosis Center (A.H.-M.), Hakadal AS, Norway; Department of Neurology (R.E.), Clinic for Rehabilitation Münster, Austria; Eugenia Epalza Rehabilitation Center (I.E.M.), Bilbao, Spain; Clinical Center in Belgrado (U.N.), Serbia; Italian Multiple Sclerosis Foundation (FISM) (A.T.), Scientific Research Area, Genoa, Italy; National MS Center (P.H.), Melsbroek; AZ Klina (G.A.), Campus De Mick, Rehabilitation, Brasschaat, Belgium; John Paul II Rehabilitation Centre for People with Multiple Sclerosis (G.S.), Borne Sulinowo, Poland; Neurological Rehabilitation Centre Quellenhof (K.G.), Sana AG, Germany; IRCSS Fondazione Don Carlo Gnocchi (D.C.), Milan, Italy; Rehabilitation and MS Center Overpelt (S.B.), Belgium; University of Colorado-Anschutz Medical Campus (J.H.); and Section of Sport Science (U.D.), Department Public Health, Aarhus University, Denmark.
773    0_
$w MED00003491 $t Neurology $x 1526-632X $g Roč. 91, č. 20 (2018), s. e1880-e1892
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30333161 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191008111321 $b ABA008
999    __
$a ok $b bmc $g 1451620 $s 1073510
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 91 $c 20 $d e1880-e1892 $e 20181017 $i 1526-632X $m Neurology $n Neurology $x MED00003491
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Archiving options